Introduction HIV-exposed uninfected children may be at risk of poor neurodevelopment. We aimed to test the impact of improved infant and young child feeding (IYCF) and improved water, sanitation and hygiene (WASH) on early child development (ECD) outcomes.
Methods Sanitation Hygiene Infant Nutrition Efficacy was a cluster randomised 2×2 factorial trial in rural Zimbabwe ClinicalTrials.gov NCT01824940). Pregnant women were eligible if they lived in study clusters allocated to standard-of-care (SOC; 52 clusters); IYCF (20 g small-quantity lipid-based nutrient supplement/day from 6 to 18 months, complementary feeding counselling; 53 clusters); WASH (pit latrine, 2 hand-washing stations, liquid soap, chlorine, play space, hygiene counselling; 53 clusters) or IYCF +WASH (53 clusters). Participants and fieldworkers were not blinded. ECD was assessed at 24 months using the Malawi Developmental Assessment Tool (MDAT; assessing motor, cognitive, language and social skills); MacArthur Bates Communication Development Inventory (assessing vocabulary and grammar); A-not-B test (assessing object permanence) and a self-control task. Intention-to-treat analyses were stratified by maternal HIV status.
Results Compared with SOC, children randomised to combined IYCF +WASH had higher total MDAT scores (mean difference +4.6; 95% CI 1.9 to 7.2) and MacArthur Bates vocabulary scores (+8.5 words; 95% CI 3.7 to 13.3), but there was no evidence of effects from IYCF or WASH alone. There was no evidence that that any intervention impacted object permanence or self-control.
Conclusions Combining IYCF and WASH interventions significantly improved motor, language and cognitive development in HIV-exposed children.
Trial registration number NCT01824940.
- early child development
- complementary feeding
- hand washing
- safe drinking water
- HIV-exposed uninfected
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
- early child development
- complementary feeding
- hand washing
- safe drinking water
- HIV-exposed uninfected
What is already known?
Globally, an estimated 43% of children fail to reach their full developmental potential.
The population of HIV-exposed uninfected (HEU) children is expanding, and reached nearly 15 million in 2017.
Children who are HEU may be at greater risk of poor early child development than HIV-unexposed children.
What are the new findings?
Compared with standard-of-care, children randomised to combined infant and young child feeding (IYCF) plus water, sanitation and hygiene (WASH) had higher total child development scores as measured by the Malawi Developmental Assessment Tool (mean difference +4.6; 95% CI 1.9 to 7.2).
Compared with standard-of-care, children randomised to combined IYCF+WASH had higher MacArthur Bates vocabulary scores (+8.5 words; 95% CI 3.7 to 13.3).
There was no evidence that IYCF or WASH alone affected child development.
What do the new findings imply?
HEU children may be particularly responsive to a package of public health interventions, which may support a targeted intervention approach to ensure that HEU children survive, thrive and reach their full potential.
Globally, 1.4 million HIV-infected women become pregnant each year, predominantly in sub-Saharan Africa. Due to increased coverage of prevention of mother-to-child transmission (PMTCT) interventions, the number of HIV-exposed uninfected (HEU) children is expanding, and reached nearly 15 million in 2017.1 HEU children have higher mortality and more frequent and more severe infections, anaemia and growth faltering than children born to HIV-negative mothers (HIV-unexposed children).2 Since stunting (linear growth faltering),3 anaemia4 and inflammation5 are all associated with impaired neurodevelopment, HEU children may be at greater risk of poor early child development (ECD) than HIV-unexposed children, although empirical evidence is limited.6 Together these observations suggest that interventions to reduce stunting, anaemia and infections may have particular benefits for the growing population of HEU children, including enhanced neurodevelopment.
The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial was designed to assess the individual and combined effects of an infant and young child feeding (IYCF) intervention and a household water, sanitation and hygiene (WASH) intervention on stunting and anaemia in HIV-unexposed and HIV-exposed Zimbabwean children.7 The WASH intervention was designed to reduce exposure to faecal microbes, and thereby prevent a subclinical inflammatory disorder of the gut termed environmental enteric dysfunction (EED), which may mediate stunting, anaemia and reduced ECD. We previously reported that the IYCF intervention reduced stunting and anaemia in HIV-unexposed8 and HIV-exposed9 children at 18 months of age, but the WASH intervention had no impact on either of these trial outcomes. A substudy, assessing the effects of the randomised interventions on ECD at 24 months of age, showed there was overall little impact of either intervention on neurodevelopment among HIV-unexposed children.10 Here, we report the impact of the randomised interventions on ECD at 24 months among HIV-exposed children, in whom we hypothesised the trial interventions may have distinct effects compared with HIV-unexposed children.
Study design and randomisation
The SHINE trial design has been reported previously; the protocol and statistical analysis plan are available at https://osf.io/w93hy Briefly, SHINE was a cluster randomised, community-based 2×2 factorial trial conducted in two contiguous rural districts in Zimbabwe. Clusters were defined as the catchment area of 1–4 village health workers (VHWs) employed by the Ministry of Health and Child Care, and were allocated to one of four treatment groups (standard-of-care (SOC), IYCF, WASH, IYCF +WASH) at a public randomisation event. A highly constrained randomisation technique achieved balance across arms for 14 variables related to geography, demography, water access and sanitation coverage. Between 22 November 2012 and 27 March 2015, VHWs identified pregnant women and referred them to trial research nurses, who enrolled women permanently residing in the study area into SHINE following written informed consent. HIV prevalence among antenatal women in the study area was 15%; we prespecified that analysis of all outcomes would be stratified by maternal HIV status.
Interventions were informed by extensive formative research and piloting.7 Behavioural change modules using interactive tools to deliver specific messages were provided by arm-specific VHWs; lesson plans and intervention tools are publicly accessible at https://osf.io/w93hy. All women were scheduled to receive 15 VHW visits between enrolment and 12 months postpartum; other family members were encouraged to participate. At each visit, previous information was reviewed before introducing new information to create a sequenced, integrated, longitudinal intervention. Between 13 and 17 months, VHWs visited monthly, providing routine care and, in active arms, delivering intervention supplies; during these visits VHWs informally encouraged participants to practise relevant behaviours. At 18 months, a review module was delivered in all arms. Key messages and supplies are outlined below, with more detail provided in the online supplementary methods:
SOC Promotion of exclusive breast feeding to 6 months, uptake of antenatal and neonatal care, PMTCT, immunisations, family planning.
IYCF All SOC messages plus (1) importance of nutrition for infant health, growth and development; (2) feeding nutrient-dense food and 20 g small-quantity lipid-based nutrient supplement (SQ-LNS; Nutriset, Malaunay, France) daily from 6 to 18 months; (3) processing locally available foods to facilitate mastication and swallowing; (4) feeding during illness; (5) dietary diversity. Monthly delivery of SQ-LNS from 6 to 18 months.
WASH All SOC messages plus (1) safe disposal of faeces; (2) hand-washing with soap at key times; (3) protection of infants from geophagia and animal faeces ingestion; (4) chlorination of drinking water and (5) hygienic preparation of complementary food. Ventilated improved pit latrine constructed within 6 weeks of enrolment; two hand-washing stations; plastic mat and play yard; monthly delivery of soap and chlorine (WaterGuard, Nelspot, Zimbabwe).
IYCF±WASH All SOC, IYCF and WASH interventions.
A latrine was constructed in non-WASH arms following trial completion. Masking for participants and fieldworkers was not possible, but investigators were blinded to trial arm.
Maternal HIV testing
Local clinics undertook antenatal HIV testing and provided antiretroviral therapy (ART) to HIV-positive women. PMTCT guidelines in Zimbabwe changed from WHO Option B (combination ART for all HIV-positive women during the pregnancy and breast feeding) to Option B+ (lifelong ART for pregnant and breastfeeding women) during the trial (from November 2013). In addition to local clinic services, we offered home HIV testing to mothers at baseline using an anti-HIV antibody rapid test algorithm (Alere Determine HIV-1/2 test, confirmed by INSTI HIV-1/2 test if positive); testing was repeated at 32 gestational weeks to detect HIV seroconversion during pregnancy. Women testing HIV-positive had CD4 counts measured (Alere Pima, Abbott) and were referred to local clinics for ART. The trial did not measure HIV viral loads.
Child HIV testing
HIV-positive women were encouraged to attend local clinics at 4–6 weeks post partum for early infant diagnosis, initiation of cotrimoxazole prophylaxis and, for HIV-infected children, ART initiation. Infants born to HIV-positive mothers were eligible for enrolment into a substudy in which biological specimens were collected longitudinally. For substudy infants, blood was tested for HIV (by PCR or rapid test, depending on age and sample) at 1, 3, 6, 12 and 18 months; infants not enrolled into the substudy were tested at 18 months. HEU children were defined as being born to HIV-positive mothers and testing HIV-negative at 18 months of age. HIV-exposed children, who were not tested at 18 months because of maternal refusal, missed visits or failure to obtain a specimen or children who had inconclusive/discordant HIV results after retesting, were classified as HIV unknown. All HIV-positive children were referred to clinics for ART initiation.
Research nurses made home visits at baseline (~2 weeks after consent), 32 weeks’ gestation and at 1, 3, 6, 12 and 18 months postpartum to assess maternal and household characteristics and trial outcomes. Intervention uptake was assessed by participant behaviours at the 12-month postnatal visit.
Infants who completed the trial and turned 2 years of age (allowable range 102–112 weeks) between 1 March 2016 and 30 April 2017 were eligible to join the ECD substudy. Children were enrolled either during the 18-month trial endpoint visit, or following the 18 month SHINE visit but before the child turned 2 years of age.
A team of 11 research nurses completed 3 weeks of residential training in ECD assessment by the team psychologist (JC) and a neurodevelopmental paediatrician (MG). Several domains of ECD were assessed.
Malawi Developmental Assessment Tool (MDAT), measuring child development in four domains: gross and fine motor coordination, language and social. Fine motor, language and social domains also measure components of cognitive development.11 The MDAT was initially validated in Malawi (a very similar setting to Zimbabwe) and then piloted on 50 Zimbabwean children.
MacArthur Bates Communicative Development Inventory (CDI), assessing language according to maternal report using vocabulary and grammar checklists.12 The test was specifically adapted for Shona speakers using a detailed protocol approved by the CDI team.13 14
A-not-B test, assessing object permanence and cognition.15
Self-control task, assessing impulsivity.16
The ECD substudy design and outcomes were prespecified in the study protocol and statistical analysis plan (https://osf.io/w93hy). The primary outcomes were MDAT total (out of 138), gross motor (out of 36), fine motor (out of 36), social (out of 30) and language (out of 36) scores; MacArthur Bates CDI vocabulary checklist (number of words known out of 99); A-not-B score (out of 10); and the proportion of children with self-control. The secondary outcomes were the proportion of children using the progressive tense, using plurals or combining two words (MacArthur Bates CDI grammar checklist).
Children with severe motor, visual, hearing or learning impairments as determined by the Washington Group questionnaire (child version)17 were excluded from analyses and referred to local clinics.
Validation and quality control
Every 6 months, nurses underwent refresher training and standardisation. Each nurse was observed while conducting an ECD assessment while a gold-standard assessor double-scored the assessment; percentage agreement had to be >85% for certification, with retraining and retesting required for those who did not meet this threshold. In addition, all 11 nurses concurrently scored the same child: average interclass correlations across standardisations were: MDAT 0.88 (95% CI 0.82 to 0.94); MacArthur Bates 0.94 (95% CI 0.90 to 0.96); A-not-B 0.85 (95% CI 0.80 to 0.90) and self-control task 0.80 (95% CI 0.76 to 0.85). Supportive supervision was undertaken during monthly field visits and nurses were provided with corrective or reinforcing feedback. A 5% subsample of assessments were video recorded, reviewed and double scored by a psychologist (JC) and a neurodevelopmental paediatrician with Shona language proficiency (GK). Percentage agreement for these video-taped assessments was 93% for MDAT fine motor, 90% for MDAT language, 97% for A-not-B and 91% for the self-control task.
All analyses were intention to treat at the child level. The absolute difference in mean score between treatment groups was estimated for tests with continuous outcomes. For tests with dichotomous outcomes, the relative risk (RR) of passing was compared between treatment groups. Primary analyses used generalised estimating equations to account for within-cluster correlation, containing two dummy variables for the two interventions, representing the main effect of the IYCF intervention (the two IYCF-containing groups compared with the two groups without IYCF) and the WASH intervention (the two WASH-containing groups compared with the two groups without WASH), unadjusted for other covariates, with an exchangeable working correlation structure. For each outcome, we estimated the statistical interaction between the IYCF and WASH interventions. When the interaction was significant (p<0.05 according to the Wald test), results are based on a regression model with three dummy variables to represent IYCF, WASH and IYCF +WASH compared with SOC, instead of the model with two terms. Adjusted analyses controlled for prespecified baseline covariates (mother’s mid-upper arm circumference, mother’s education, mother’s employment, maternal health perception, maternal capabilities, improved latrine, low birth weight, prematurity, sex, calendar month, fieldworker, decimal age), which were initially assessed in bivariate analyses to identify those with an important association with the outcome (for dichotomous outcomes: p<0.2 or RR >2.0 or <0.5; for continuous outcomes: p<0.2 or difference >0.25 SD). Selected covariates were entered in a multivariable regression model; a forward stepwise selection procedure was implemented with p<0.2 to enter. A log-binomial specification was used to estimate RRs. Methods for comparing study arms while handling within-cluster correlation included multinomial and ordinal regression models with robust variance estimation, and Somers’ D for medians, were all implemented in Stata V.14.
In a sensitivity analysis, HIV-positive and HIV-unknown children were excluded. A subgroup analysis by child gender was planned if there was a significant interaction between gender and study arms (as defined above).
The sample size of the ECD substudy was based on detecting clinically relevant differences among HIV-unexposed children10; there was no specific sample size calculation for HIV-exposed children.
Patient and public involvement
We did not directly include patient and public involvement in this trial, but all community activities were discussed with traditional and elected leaders in both study districts, who provided advice through the District Health Executive, Social Services Committee and Rural District Council. A film of the SHINE trial is being made with community participation to capture the experience of being involved in a community-wide trial. The film will be screened in the two rural districts where SHINE was conducted.
Role of funder
Study funders approved the trial design, but were not involved in data collection, analysis or interpretation, nor decisions related to publication. The corresponding author had full access to all study data and ultimate responsibility for the decision to submit for publication.
Trial oversight and registration
An independent data safety and monitoring board reviewed interim adverse event data.
Among 5280 enrolled pregnant women, 726 tested HIV-positive during the pregnancy; of 738 infants born to these mothers, 475 were eligible for the ECD substudy, and 323 (68% of eligible) were enrolled from 142 clusters (figure 1) during the period of enrolment (between 1 March 2016 and 30 April 2017). Of the 152 children not enrolled, 94 (62%) had relocated temporarily or permanently from their study home; 41 (27%) were not reachable by telephone or home visit to determine availability and interest in joining the ECD substudy; 8 (5%) declined; 4 (3%) could not be scheduled at a mutually agreeable time within the required age window; and 3 (2%) died between 18 and 24 months of age.
At baseline, approximately half of all household members practised open defecation, and just over one-third had a household latrine (table 1). About 40% of households consumed a minimally diverse diet. Among mothers, mean (SD) CD4 count was 461 (218) cells/µL; 88% and 67% received ART and cotrimoxazole, respectively, during the pregnancy. There were some minor baseline imbalances in improved latrine ownership, observed chicken faeces in households, wealth index, mode of delivery and birth weight between arms. HIV-positive mothers who enrolled in the ECD substudy were about 3 years older than those who did not enrol, SOC and IYCF +WASH enrolled mothers had higher institutional delivery (92% vs 74%) while IYCF and WASH arms were similar; other baseline characteristics of mother–infant dyads who enrolled or did not enrol were similar (online supplementary table 1).
Delivery and uptake of interventions
Across randomised arms, the fidelity of providing intervention supplies (WASH hardware, liquid soap, chlorine and SQ-LNS) was high, and >90% of expected behavioural change modules were delivered by VHWs (table 2). Open defecation was virtually eliminated in the WASH arms: <1% households reported practising open defecation compared with half in non-WASH arms. Among WASH compared with non-WASH households, fewer mothers reported ever seeing their child ingest soil and chicken faeces. Over 90% of children in all treatment arms were still breast feeding at 12 months. A higher proportion of infants in the IYCF arms had consumed a diet that met minimum dietary diversity and had consumed animal-source, iron-rich and vitamin A-rich foods in the previous day. Almost all children in the IYCF arms had consumed SQ-LNS in the previous 24 hours.
Effect of randomised intervention on ECD outcomes
The age at the ECD assessment visit was very similar across trial arms (SOC: mean (SD) 105.4 (2.2) weeks; IYCF: 105.0 (2.0) weeks; WASH: 105.1 (1.9) weeks and IYCF+WASH 105.6 (2.1) weeks). Of the 323 enrolled children, two (1%) were excluded due to severe disability, and three (1%) were excluded because they were subsequently found to be outside the predefined age window (102–112 weeks). Two children (both in the IYCF+WASH arm) were assessed after the substudy enrolment period ended, but were otherwise eligible and were included. The final analysis therefore included 318 HIV-exposed children (figure 1), of whom 6 were HIV-positive, 300 HEU and 12 HIV-unknown.
There was a significant interaction between the WASH and IYCF interventions for the total MDAT score and MacArthur Bates CDI vocabulary checklist; therefore, scores for these tests were analysed and presented separately for the four treatment arms. There was no interaction between the randomised interventions for the object permanence and self-control tests; therefore, the main effects of IYCF and WASH are presented for these tests.
At 24 months, the total MDAT score was higher among children in the IYCF +WASH group compared with the SOC group (unadjusted difference +4.6; 95% CI 1.9 to 7.2). This difference corresponds to a 0.50 SD increase in total MDAT score, and was driven by higher scores in all components of the MDAT test (table 3). In adjusted analyses, the total MDAT score remained significantly higher in the IYCF +WASH group (adjusted difference +3.1; 95% CI 0.9 to 5.3); differences in individual components of the MDAT score were attenuated and no longer reached statistical significance for the fine motor and language component scores. There was no evidence of effect from the IYCF or WASH interventions alone, either on total MDAT score or any of the MDAT component scores.
MacArthur Bates CDI vocabulary and grammar checklists
Compared with SOC, children in the IYCF +WASH arm had higher MacArthur Bates CDI vocabulary scores (+8.5 words; 95% CI 3.7 to 13.3), corresponding to an increase of 0.44 SD. Twice as many children in the IYCF +WASH arm reportedly used plurals (RR 2.08; 95% CI 0.98 to 4.41), although this difference was no longer significant in the adjusted analysis. There was no evidence of an effect of IYCF +WASH on the proportion of children combining two words or using the progressive tense. There was no evidence that either the IYCF or WASH interventions, when implemented alone, impacted any component of the MacArthur Bates CDI score (table 3).
Object permanence and self-control
There was no interaction between interventions for either test, so the IYCF arms were compared with non-IYCF arms, and the WASH arms were compared with non-WASH arms. There was no evidence of differences between intervention groups in object permanence or in the proportion of children with self-control (table 3). Inferences were similar in adjusted analyses.
Sensitivity and subgroup analyses
When effects of the interventions were restricted to children confirmed as HEU (ie, removing children who were HIV-positive and HIV-unknown at 18 months of age), overall findings were similar (table 4). There was a significant interaction between child gender and randomised interventions for the total MDAT score. Results stratified by gender showed that among girls, those in the combined IYCF+WASH arm had significantly higher motor, language and social scores than those in the SOC arm. Among boys, those in the combined IYCF+WASH arm had significantly higher language and social scores than those in the SOC arm, but there was no evidence of an intervention effect on motor scores (online supplementary table 2).
In this analysis of children born to HIV-positive mothers in rural Zimbabwe, a package combining IYCF and WASH interventions significantly improved motor, language and cognitive development at 2 years of age compared with those receiving enhanced SOC. The same IYCF and WASH interventions when delivered individually (rather than as a combined package) had no impact on ECD at 2 years of age. These findings are contrary to previously reported findings from the SHINE trial among a larger group of 3686 HIV-unexposed children, in whom the IYCF and WASH interventions, delivered either alone or together, had no meaningful impact on ECD. We suggest from these collective findings that HIV exposure in early life is a distinct challenge and that HEU children may be particularly responsive to a package of interventions to improve neurocognitive development.
The SHINE trial was designed to evaluate the effects of IYCF and WASH on linear growth and haemoglobin, which are both associated with child development. In the SHINE trial, among children born to HIV-negative mothers, the IYCF intervention increased LAZ by 0.16 (95% CI 0.08 to 0.23) and haemoglobin by 2.03 (95% CI 1.28 to 2.79) g/L at 18 months of age, while the WASH intervention had no effect on these outcomes.8 Among 668 children born to HIV-positive mothers, the effects of the IYCF intervention exceeded those seen in the HIV-unexposed group, increasing mean Length for Age Z score (LAZ) by 0.26 (95% CI 0.09 to 0.43) and haemoglobin by 2.9 (95% CI 0.9 to 4.9) g/L, while the WASH intervention had no effect on these outcomes.9 In both analyses, implementing WASH together with IYCF had no additional impact on stunting or anaemia compared with delivering IYCF alone. In the current analysis, HIV-exposed children randomised to a package of combined IYCF +WASH interventions had significantly improved motor, social and language development compared with HIV-exposed children receiving SOC interventions; by contrast, those randomised to receive either the IYCF or WASH intervention alone had similar ECD scores to control children. It is difficult to explain why combining IYCF and WASH improved neurodevelopment in HIV-exposed children when we found little evidence of benefit from either intervention delivered alone. We did not see this level of synergy between the interventions in HIV-unexposed children, although the study was not powered to distinguish between interactions in these two subgroups. However, among the HIV-exposed children, we found consistent, statistically significant improvements across multiple tests of global child development. These included specific motor, social and language scores, which exhibited substantial magnitudes of effect between IYCF +WASH and SOC of 0.4–0.5 SD.18 19 These effect sizes effects are considerable for child development at this age.
We have previously reported that HEU children had evidence of modestly reduced developmental scores compared with HIV-unexposed children in SHINE,20 but we suggest from the results of this current study that they may also be more responsive to interventions (online supplementary table 3). The IYCF intervention was designed to improve nutrient intake during a critical period of growth and brain development, while the WASH intervention was designed to reduce exposure to pathogens and to prevent a subclinical inflammatory disorder of the gut termed EED. Perhaps ECD improvements in these vulnerable children are only realised when gut health and nutrient requirements are both addressed simultaneously. A healthier intestinal milieu may facilitate absorption and prevent wastage of nutrients from the IYCF intervention, or modulate the microbiota–gut–brain axis to improve neurodevelopment. Further planned laboratory studies of EED biomarkers, pathogen carriage and growth hormone activity will help to address the underlying pathways. We anticipated that the infant feeding intervention alone would lead to improvements in ECD, since IYCF reduced stunting at 18 months of age, but IYCF alone had no evidence of benefit for neurodevelopment. There was no evidence for a synergistic effect of IYCF and WASH on linear growth at 18 months of age, although children randomised to this group did have a larger head circumference (mean Z-score −0.38, compared with SOC −0.55, IYCF −0.51 and WASH −0.53). It is, therefore, plausible that HIV-exposed children prioritise head growth over linear growth; however, this difference was already apparent from as early as 1 month of age. We are, therefore, uncertain whether our findings reflect a true effect of the combined intervention on ECD, and we also need to consider alternative explanations for these results.
First, it is possible that there was residual confounding in this substudy. Although our findings remained consistent after adjusting for known confounders, there may have been imbalances in unmeasured factors at baseline. This study was nested within a larger randomised controlled trial, where children were identified and offered enrolment during the period of this substudy if they met strict age criteria. There were some differences in rates of enrolment into the ECD study across the treatment arms which may have created bias. There was balance on baseline demographics across trial arms for those who were enrolled in the substudy, which increases our confidence in the internal validity of our findings. Overall, there was similarity between those who were enrolled and not enrolled from the main SHINE trial; however, there were some differences that may influence external validity, such as a higher rate of institutional delivery and a shorter walk-time to water in the IYCF+WASH arm among those assessed for ECD compared with those not assessed.
Given our incomplete understanding of the interlinking pathways between HIV exposure and neurodevelopment, it is unlikely that all factors were accounted for in our analyses. For example, it is possible that children in the IYCF-only group had more risk factors (constraints at the maternal, child and household level) for poor ECD which we have not been able to evaluate compared with other groups so that the benefits of the IYCF intervention were only observed in the combined IYCF +WASH group. These risk factors may be related to the caregiver’s capacity to provide responsive caregiving, in turn, affecting the child’s development. Second, the households in the combined IYCF +WASH group received more trial inputs than the IYCF-only or WASH-only groups. In designing SHINE, we were careful to ensure that all families received the same number of VHW contacts; however, visits in the IYCF +WASH arm were longer and households in the combined IYCF +WASH group received more hardware (latrine and tippy taps) and commodities (chlorine, soap and SQ-LNS) than the IYCF-only or WASH-only groups. Both the IYCF and WASH modules may have increased the interactions between mother and child (eg, washing child’s hands and providing responsive feeding) and given the strong evidence linking positive maternal–child interaction and ECD outcomes, it is possible that these combined interventions in some way enabled an increase in interaction time to impact ECD scores. In addition, the positive impact of receiving inputs which included longer visits as well as the material goods (a latrine, tippy tap and nutritional supplements) may have positively impacted maternal mental health and well-being which may have influenced ECD outcomes.21 22 Quality of caregiving and responsivity plays a critical role within ECD intervention studies and it may be that the additional inputs and VHW time that were provided in the combined group with both curricula improved maternal well-being and enabled increased responsivity more in the vulnerable HIV-positive women than in HIV-negative women, and this, in turn, improved ECD in their children. In other words, the ‘double’ training pack received from VHWs along with the additional inputs may have enabled mothers to be more responsive to the health and developmental needs of their HEU children. This may also reflect the fact that we saw a specific neurodevelopmental profile change in the areas of language and fine motor development (both closely linked to responsive caregiving) than in the gross motor and social components of development. With this in mind, a package of interventions which enhances quality caregiving and responsivity as much as possible may be what is needed to meaningfully impact ECD.
We found a significant interaction between child gender and trial intervention. Among girls, compared with the SOC arm, those in the combined IYCF+WASH arm had significantly higher motor, language and social scores. Among boys, compared with the SOC arm, those in the combined IYCF+WASH arm had significantly higher language and social scores, but there was no evidence of an effect on motor scores. Among children in the SOC arm, boys generally had poorer language and social scores than girls, whereas motor scores were similar; it is possible that whereas girls generally responded to IYCF+WASH interventions in all domains, boys only responded when developmental delays were more pronounced.
This analysis has several strengths. To our knowledge, this is the first intervention trial evaluating ECD outcomes in HIV-exposed children, who are an expanding population in regions with high ongoing antenatal HIV prevalence. By using several different developmental assessment tools, we were able to thoroughly assess ECD across a broad range of domains. We adapted our assessment tools for use in rural Zimbabwe, and undertook extensive piloting, quality control and standardisation. We were able to report the findings specifically for HEU children, who now comprise the vast majority of children born to HIV-infected mothers. However, an important limitation of this study is that SHINE was originally designed to assess the effects of IYCF and WASH interventions on stunting and anaemia, and was powered to evaluate these outcomes in HIV-unexposed children; the ECD component was a substudy of the trial, and the current findings focus only on HIV-exposed children. Further studies are needed to confirm our findings in other populations.
In summary, HIV-exposed children randomised to a combined intervention of improved ICYF and improved WASH had significant improvements in ECD at 2 years of age, while those receiving either the IYCF or WASH intervention alone had no evidence of ECD benefit. Importantly, combining the IYCF and WASH interventions closed the developmental gap between HEU and HIV-unexposed children. Although the mechanisms that underlie the synergistic effects of IYCF and WASH on ECD in HIV-exposed children remain unclear, our study implicates nutrition and WASH as contributing factors in the neurocognitive development of children exposed to HIV in early life that warrant further study. Thus, despite having poorer health outcomes than HIV-unexposed children in the absence of any interventions, we suggest from the results of this study, that HEU children may be more responsive to public health interventions. The interventions we provided combined WASH improvements with nutritional support, which goes beyond what current PMTCT programmes provide. Combining these approaches with specific nurturing care and early education interventions, in line with the Nurturing Care Framework strategy, may bring additional benefits to improve human capital in this expanding global population.
The SHINE trial was funded by the Bill & Melinda Gates Foundation (OPP1021542 to Johns Hopkins Bloomberg School of Public Health and OPP1143707 to Zvitambo Institute for Maternal and Child Health Research); the United Kingdom Department for International Development (DFID/UKAID); Wellcome Trust (093768/Z/10/Z, 108065/Z/15/Z and 203905/Z/16/Z); Swiss Agency for Development and Cooperation (8106727); UNICEF (PCA-2017–0002); National Institutes of Health (R01 HD060338/HD/NICHD). We thank all the mothers, babies and their families who participated in SHINE. We gratefully acknowledge the leadership and staff of the Ministry of Health and Child Care in Chirumanzu and Shurugwi districts and Midlands Province (especially environmental health, nursing and nutrition) for their roles in operationalisation of the study procedures. We acknowledge the Ministry of Local Government officials in each district who supported and facilitated field operations. We are particularly indebted to Phillipa Rambanepasi and her team for proficiently managing all the finances and Virginia Sauramba for managing compliance issues. Finally, we are very thankful for our programme officers at the Gates Foundation and DFID who enthusiastically worked with us over a long period of time to make SHINE happen.
Handling editor Seye Abimbola
Twitter @jayachandna, @NtoziniRobert, @mjgladstone
Contributors JC was involved with data curation, formal analysis, methodology, project administration, validation, writing—original draft, writing—review and editing. RN was involved with data curation, formal analysis, methodology, validation, writing—review and editing. CE was involved with formal analysis, methodology, and reviewing and editing. GK was involved with conceptualisation, methodology, supervision, validation, writing—review and editing. BC was involved with data curation, formal analysis, methodology and reviewing and editing. FM was involved with data curation, methodology, project administration, validation, writing—review and editing. KM was involved with data curation, methodology and review and editing. NT was involved in data curation, methodology, project administration, writing—review and editing. BM was involved in data curation, analysis and review and editing. MM was involved in conceptualisation, data curation, funding acquisition, investigation, methodology, project administration, resources, wupervision, writing—review and editing. LHM was involved in conceptualisation, formal analysis, investigation, methodology, writing—review and editing. JHH was involved with conceptualisation, data curation, funding acquisition, investigation, methodology, project administration, resources, supervision, writing—review & editing. AP was involved with conceptualisation, data curation, funding acquisition, investigation, methodology, project administration, resources, supervision, writing—review and editing. MG was involved with conceptualisation, data curation, methodology, supervision, validation, writing—original draft, writing—review and editing.
Funding Funded by the Bill & Melinda Gates Foundation (OPP1021542 and OPP1143707); the United Kingdom Department for International Development (DFID/UKAID); Wellcome Trust (093768/Z/10/Z, 108065/Z/15/Z and 203905/Z/16/Z); Swiss Agency for Development and Cooperation; US National Institutes of Health (2R01HD060338-06); and UNICEF (PCA-2017-0002).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The Medical Research Council of Zimbabwe and the Institutional Review Board of the Johns Hopkins Bloomberg School of Public Health approved the study protocol.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on request. Data will be freely available as individual participant data with an accompanying data dictionary at http://ClinEpiDB.org from late 2019. This platform is charged with ensuring that epidemiological studies are fully anonymised by removing all personal identifiers and obfuscating all dates per participant through application of a random number algorithm to comply with the ethical conduct of human subjects research. Researchers must agree to the policies and comply with the mechanism of ClinEpiDB to access data housed on this platform. Prior to that time, the data are housed on the ClinEpiDB platform at the Zvitambo Institute for Maternal and Child Health Research and available on request from Virginia Sauramba (email@example.com).
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.